Masimo Quick Ratio (MASI) starting from the first quarter 2026 to first quarter 2025, Financial Strength Trends, Rankings, Financial Ratios - CSIMarket
CSIMarket
 


Masimo Corp  (NASDAQ: MASI)

Masimo's Quick Ratio

MASI's quarterly Quick Ratio and Cash & cash equivalent, Current Liabilities growth


Current Liabilities decreased faster than Masimo's Cash & cash equivalent, this led to improvement in Masimo's Quick Ratio to 0.38, Quick Ratio remained below Masimo Corp average.

Within Medical Equipment & Supplies industry 155 other companies have achieved higher Quick Ratio than Masimo in first quarter 2026. While Quick Ratio total ranking in the first quarter 2026 has deteriorated compared to the prior quarter from 2681 to 2873.

Explain Quick Ratio?
How much Cash & cash equivalents MASI´s has?
What are MASI´s Current Liabilities?




MASI Quick Ratio (Apr 04 2026)
Q1
(Jan 03 2026)
Q4
(Sep 27 2025)
Q3
(Jun 28 2025)
Q2
(Mar 29 2025)
Q1
Y / Y Current Liabilities Change -33.22 % -0.32 % -34.85 % 24.13 % 10.55 %
Y / Y Cash & cash equivalent Change -4.74 % 23.22 % 97.03 % 15.43 % -17.01 %
Quick Ratio MRQ 0.38 0.37 0.84 0.25 0.27
MASI's Total Ranking # 2873 # 2681 # 1723 # 2562 # 2151
Seq. Current Liabilities Change -20.83 % 11.17 % -37.56 % 21.51 % 18.19 %
Seq. Cash & cash equivalent Change -18.19 % -51.23 % 108.76 % 14.37 % 5.83 %



Quick Ratio first quarter 2026 Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 156
Healthcare Sector # 763
Overall Market # 2873


Quick Ratio Statistics
High Average Low
6.2 2.41 0.23
(Mar 30 2019)   (Sep 30 2023)




Financial Statements
Masimo's Current Liabilities $ 325 Millions Visit MASI's Balance sheet
Masimo's Cash & cash equivalent $ 125 Millions Visit MASI's Balance sheet
Source of MASI's Sales Visit MASI's Sales by Geography


Cumulative Masimo's Quick Ratio

MASI's Quick Ratio for the trailling 12 Months

MASI Quick Ratio

(Apr 04 2026)
12 Months
(Jan 03 2026)
12 Months
(Sep 27 2025)
12 Months
(Jun 28 2025)
12 Months
(Mar 29 2025)
12 Months
Y / Y Current Liabilities TTM Growth -12.65 % -1.98 % -7.84 % 3.8 % -4.6 %
Y / Y Cash & cash equivalent TTM Growth 36.18 % 30.86 % 17.68 % -2.11 % -8.93 %
Quick Ratio TTM 0.44 0.4 0.38 0.27 0.28
Total Ranking TTM # 4078 # 2987 # 3293 # 2765 # 3088
Seq. Current Liabilities TTM Growth -8.7 % -0.07 % -9.61 % 5.92 % 2.45 %
Seq. Cash & cash equivalent TTM Growth -0.83 % 4.01 % 27.34 % 3.69 % -4.71 %


On the trailing twelve months basis Current Liabilities decreased faster than Masimo's average Cash & cash equivalent, this led to increase in in Masimo's Quick Ratio to 0.44, Quick Ratio remained below MASI average.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operating within Medical Equipment & Supplies industry 204 other companies have achieved higher Quick Ratio than Masimo. While Quick Ratio total ranking has deteriorated compared to the previous twelve months ending in the fourth quarter 2025 from 2987 to 4078.

Explain Quick Ratio?
How much Cash & cash equivalents MASI´s has?
What are MASI´s Current Liabilities?

TTM Quick Ratio Company Ranking
Within: No.
Within the Medical Equipment & Supplies Industry # 205
Healthcare Sector # 904
Within the Market # 4078


trailing twelve months Quick Ratio Statistics
High Average Low
4.32 1.62 0.25
(Dec 28 2019)   (Mar 29 2025)




Companies with similar Quick Ratio in the quarter ending Apr 04 2026, within Medical Equipment & Supplies Industry Quick RatioApr 04 2026 MRQ Cash & cash equivalentApr 04 2026 MRQ Current Liabilities
Precision Optics Corporation Inc   1.05 $ 10.680  Millions$ 10.193  Millions
Lifeward ltd   1.00 $ 11.422  Millions$ 11.418  Millions
Sanara Medtech Inc   0.99 $ 13.594  Millions$ 13.701  Millions
Koru Medical Systems Inc   0.99 $ 8.768  Millions$ 8.852  Millions
Lucid Diagnostics Inc   0.98 $ 27.876  Millions$ 28.477  Millions
West Pharmaceutical Services Inc   0.90 $ 521.400  Millions$ 580.000  Millions
Medline Inc   0.88 $ 2,236.000  Millions$ 2,536.000  Millions
Stryker Corp  0.87 $ 3,004.000  Millions$ 3,452.000  Millions
Haemonetics Corporation  0.87 $ 245.440  Millions$ 282.599  Millions
Qt Imaging Holdings Inc exact Name Of Registrant As Specified In Its Charter _______________________  0.86 $ 6.900  Millions$ 8.058  Millions
Neuronetics Inc   0.83 $ 18.964  Millions$ 22.863  Millions
Integra Lifesciences Holdings Corp  0.83 $ 265.502  Millions$ 321.291  Millions
Establishment Labs Holdings Inc   0.82 $ 68.101  Millions$ 83.153  Millions
Lifestance Health Group Inc   0.81 $ 194.797  Millions$ 239.732  Millions
Medtronic Plc  0.80 $ 9,313.000  Millions$ 11,658.000  Millions
Glucotrack Inc   0.79 $ 3.929  Millions$ 4.975  Millions
Invo Fertility Inc   0.77 $ 4.905  Millions$ 6.356  Millions
Lensar Inc   0.76 $ 13.495  Millions$ 17.799  Millions
Pro dex Inc   0.75 $ 10.979  Millions$ 14.636  Millions
Cerus Corporation  0.75 $ 80.425  Millions$ 107.383  Millions
Embecta Corp   0.75 $ 184.900  Millions$ 247.300  Millions
Electrocore Inc   0.74 $ 8.830  Millions$ 11.935  Millions
Livanova Plc  0.71 $ 539.706  Millions$ 762.478  Millions
Innovage Holding Corp   0.71 $ 138.588  Millions$ 195.888  Millions
Privia Health Group Inc   0.70 $ 419.524  Millions$ 599.184  Millions
Cadre Holdings inc   0.68 $ 41.272  Millions$ 60.823  Millions
Interpace Biosciences Inc   0.67 $ 2.647  Millions$ 3.962  Millions
Orthofix Medical Inc   0.65 $ 120.278  Millions$ 184.333  Millions
Msa Safety Inc  0.64 $ 180.158  Millions$ 281.267  Millions
Stereotaxis Inc   0.63 $ 14.616  Millions$ 23.086  Millions

Date modified: 2026-09-26T07:16:19+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.